查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1969421

内视镜液体管理市场：以内视镜类型、工作流程方法、最终用户和通路划分－2026-2032年全球预测

Endoscopy Fluid Management Market by Endoscope Type, Workflow Method, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，内视镜液体管理市场价值将达到 6.8684 亿美元，到 2026 年将成长至 7.3033 亿美元，到 2032 年将达到 11.3532 亿美元，复合年增长率为 7.44%。

主要市场统计数据
基准年 2025 6.8684亿美元
预计年份：2026年 7.3033亿美元
预测年份 2032 11.3532亿美元
复合年增长率 (%) 7.44%

内视镜液体管理策略实施：连结临床安全、营运效率以及医疗领域不断变化的监管和技术因素

内视镜液体管理涉及病人安全、手术容量和医疗设备的合理管理，直接影响医疗机构如何提供微创诊断和治疗。器械设计的进步、监管力度的加强以及日益增长的报销压力，使得液体处理和再处理流程成为新的营运重点。临床团队在努力维持手术容量的同时，力求将感染风险降至最低，因此，从人工冲洗到自动化再处理平台，液体管理系统和工作流程不再只是营运层面的问题，而是策略重点。

自动化、一次性策略和数位整合如何重塑内视镜液体管理实践，优先考虑安全性、处理能力和可追溯性。

内视镜液体管理领域正经历一场变革，这主要归因于三个因素：自动化再处理技术的进步、对感染预防日益增长的期望以及一次性技术的快速普及。随着医疗机构优先考虑检验且可重复的清洁流程，以减少人为错误并提高处理能力，自动化和半自动化再处理平台正从小众应用程式走向主流选择。同时，人们对医疗设备相关感染疾病的日益关注以及监管机构对可验证的再处理结果的日益重视，使得可追溯性、文件记录和检验成为至关重要的采购标准。

2025 年关税变化对内视镜液体管理采购、供应链韧性和技术采用的营运和策略影响分析。

2025年的关税政策变化对管理内视镜清洗液及相关设备的机构而言，具有重大的营运和策略意义。关税上涨和贸易摩擦加剧可能会增加国际采购的再处理设备、耗材和替换零件的到岸成本。这将迫使采购团队寻找替代供应商、协商长期合约并重新评估资本购买计画。因此，一些采购者可能会考虑加快对国内製造合作伙伴的投资，或扩大供应商组合，纳入能够吸收或缓解关税波动影响的区域分销商。

基于细分的关键洞察揭示了最终用户画像、分销管道、内视镜类型和工作流程方法如何决定解决方案的优先顺序和采购选择。

细分市场分析揭示了临床环境和采购管道的差异如何影响液体管理系统的优先排序和投资选择。按最终用户（门诊手术中心、诊所、诊断中心和医院）分类的医疗机构在规模、病例复杂程度和资金获取方面存在差异。门诊手术中心和诊所往往优先考虑紧凑、经济高效的解决方案，以最大限度地减少人员投入和面积。而医院和大型诊断中心则通常寻求高通量、全自动的仪器系统，以支援复杂的手术流程和详细的可追溯性要求。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势和实施模式差异，影响采购、合规和商业化策略。

区域趋势影响着美洲、欧洲、中东和非洲以及亚太地区液体管理解决方案的竞争定位、监管重点和应用路径。在美洲，成熟的临床市场以及集中的感染预防标准和报销体系，使得检验的自动化系统、完善的文件记录和强大的服务网络更受青睐。该地区的采购决策往往需要在临床性能、生命週期成本和营运效率之间取得平衡，这反映了电子追踪和合规性技术的广泛应用。

供应商如何透过结合检验的自动化、模组化产品设计、卓越的服务和策略伙伴关係来获得竞争优势，以满足临床和营运要求。

流体管理生态系统中的主要企业正优先考虑互通性、检验的工作流程以及扩大服务范围，以满足由安全性和效率目标驱动的需求。策略性倡议日益包括整合再处理设备和仪器追踪平台、扩展现场服务网路以及提供培训计划，以帮助临床团队满足不断变化的监管和认证标准。那些将完善的售后服务与明确的再处理有效性证据相结合的公司，正在增强感染预防和临床领导者对其的信任。

为临床、采购和供应商领导者提供实际有效的建议，以提高液体管理系统的安全性、韧性和效率。

行业领导者应优先考虑以下关键倡议，以使投资与新的临床和营运需求保持一致：首先，建立互通性和检验的文件功能，以支持合规性并减轻人工记录的负担。投资于可与现有电子病历和器械追踪软体整合的系统，将简化工作流程并创建可衡量的审核追踪，从而满足感染预防相关人员的要求。其次，采用灵活的采购框架，支援混合医疗设备配置，使医疗机构能够根据手术类型、感染风险和治疗目标，平衡可重复使用和一次性器械的使用。

为了确保获得切实可行的见解，我们采用了严谨的混合调查方法，结合了初步访谈、监管分析、供应商分析和迭代专家检验。

本研究采用结构化的混合方法，旨在确保分析的严谨性和实际应用价值。研究以临床负责人、感染控制专家、采购经理和服务经理等不同医疗机构的人员为一级资讯来源，进行了深入访谈，以了解实际运作和决策因素。此外，研究还结合监管指南、医疗设备标籤要求和公开标准，对这些定性资讯进行三角验证，以检验与合规性相关的观察结果。

一份简洁、综合的分析报告，重点阐述了临床安全、工作流程现代化和供应链韧性如何共同作用，以改善内视镜液体管理的效果。

总之，内视镜液体管理将日益成为临床安全、工作流程效率和供应链策略交汇的关键所在。自动化和数位化整合的技术进步，以及人们对一次性器材和可重复使用器材偏好的转变，既为医疗服务提供者和供应商带来了机会，也带来了权衡取舍。关税趋势和区域差异进一步加剧了采购和营运规划的复杂性，凸显了製定以供应韧性和检验的性能为优先的灵活策略的必要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 内视镜清洗液市场（以内视镜类型划分）

  • 软式内视镜
  • 硬式内视镜

第九章 内视镜清洗液市场：工作流程方法

  • 自动化
    • 全自动
    • 半自动
  • 手动的
    • 人工清洁
    • 人工高级消毒

第十章 内视镜清洁液市场：依最终用户划分

  • 门诊手术中心
  • 诊所
  • 诊断中心
  • 医院

第十一章 内视镜清洁液市场：依通路划分

  • 直销
  • 销售代理
  • 电子商务

第十二章 内视镜清洁液市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 内视镜清洗液市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 内视镜清洁液市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国内视镜清洗液市场

第十六章：中国内窥镜清洗液市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Arthrex, Inc.
  • B. Braun Medical Inc.
  • Boston Scientific Corporation
  • ConMed Corporation
  • Cook Medical LLC
  • Fujifilm Holdings Corporation
  • Hologic Inc.
  • HOYA Corporation
  • Johnson & Johnson
  • KARL STORZ SE & Co. KG
  • Medtronic plc
  • Olympus Corporation
  • Richard Wolf GmbH
  • Smith & Nephew plc
  • STERIS plc
  • Stryker Corporation
Product Code: MRR-535C629188F7

The Endoscopy Fluid Management Market was valued at USD 686.84 million in 2025 and is projected to grow to USD 730.33 million in 2026, with a CAGR of 7.44%, reaching USD 1,135.32 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 686.84 million
Estimated Year [2026] USD 730.33 million
Forecast Year [2032] USD 1,135.32 million
CAGR (%) 7.44%

A strategic introduction to endoscopy fluid management linking clinical safety, operational efficiency, and evolving regulatory and technological drivers across care settings

Endoscopy fluid management sits at the intersection of patient safety, procedural throughput, and device stewardship, shaping how healthcare providers deliver minimally invasive diagnostics and therapeutics. Advances in device design, heightened regulatory scrutiny, and evolving reimbursement pressures have converged to put fluid handling and reprocessing practices under renewed operational focus. As clinical teams strive to minimize infection risk while preserving procedure capacity, the systems and workflows that govern fluid management - from manual cleaning to automated reprocessing platforms - now represent a strategic priority rather than a purely operational concern.

Clinicians, supply chain leaders, and infection prevention specialists are adapting to a landscape where traceability, validated cleaning protocols, and compatibility between consumables and reprocessing equipment drive procurement and policy decisions. Consequently, technology adoption decisions increasingly reflect not only clinical efficacy but also lifecycle costs, staff time savings, and risk mitigation considerations. Given these dynamics, stakeholders require a concise, evidence-based orientation to the drivers, constraints, and opportunities that will determine how endoscopy fluid management evolves over the near to medium term.

This introduction frames the subsequent analysis by linking clinical imperatives with operational realities. It positions fluid management as a multi-stakeholder challenge that demands integrated solutions spanning device innovation, workflow redesign, training programs, and supplier engagement. With that context established, readers will be better equipped to interpret the subsequent sections that explore shifts in technology, trade policy impacts, segmentation-level implications, and actionable recommendations for leaders across care settings.

How automation, single-use strategies, and digital integration are reshaping endoscopy fluid management practices to prioritize safety, throughput, and traceability

The endoscopy fluid management landscape is undergoing transformative shifts driven by three converging forces: advances in reprocessing automation, heightened infection prevention expectations, and the rapid emergence of single-use technologies. Automated and semi-automated reprocessing platforms are moving from niche adoption to mainstream consideration as facilities prioritize validated, repeatable cleaning cycles that reduce human error and enhance throughput. At the same time, growing concern about device-associated infections and increasing regulatory emphasis on demonstrable reprocessing outcomes have elevated traceability, documentation, and validation as procurement criteria.

Simultaneously, single-use and hybrid device strategies are altering vendor relationships and capital planning. These disposable options reduce reprocessing burden and certain cross-contamination risks, but they also reframe cost-benefit discussions around waste management, environmental considerations, and operational logistics. Together, these technology trends prompt health systems to reassess existing asset mixes and shift investment toward solutions that optimize staff time, lower infection risk, and deliver measurable compliance documentation.

Moreover, workflow modernization is now anchored by digital integration. Reprocessing equipment increasingly offers interoperability with electronic health records and instrument tracking systems, enabling end-to-end visibility of device status and maintenance history. This digital layer supports predictive maintenance, inventory optimization, and evidence-based policy enforcement. In sum, the landscape is moving toward integrated, validated, and digitally enabled fluid management models that better align clinical safety with operational performance.

Analyzing the operational and strategic consequences of 2025 tariff shifts on procurement, supply chain resilience, and technology adoption in endoscopy fluid management

Tariff policy changes in 2025 have introduced notable operational and strategic implications for entities managing endoscopy fluids and associated devices. Increased duties and trade friction can elevate the landed cost of reprocessing equipment, consumables, and replacement parts that are sourced internationally, which in turn pressures procurement teams to seek alternative suppliers, negotiate longer-term agreements, or re-evaluate capital acquisition timelines. As a result, some purchasers may accelerate investments in domestic manufacturing partners or broaden supplier portfolios to include regional distributors that can absorb or mitigate tariff-related volatility.

Beyond direct cost effects, tariffs reshape supply chain resilience considerations. Healthcare providers now weigh the trade-off between lowest-price sourcing and supply security, particularly for critical consumables and specialized components with limited alternative manufacturers. This trend encourages greater emphasis on dual sourcing, inventory buffering, and contractual clauses that address trade risk. In parallel, suppliers facing tariff-driven margin compression may pursue cost containment through localization of assembly, redesign for lower-cost components, or strategic partnerships with distribution networks.

Finally, elevated cross-border costs influence innovation pathways and adoption choices. Where tariffs increase the expense of reusable endoscopes or sophisticated automated reprocessors, some stakeholders may accelerate transition toward single-use devices or choose reprocessing technologies that rely on locally sourced consumables. Conversely, tariff uncertainty can also delay procurement decisions and slow rollout of new systems. In short, trade policy in 2025 amplifies the importance of supply chain strategy and forces both purchasers and vendors to adopt more flexible, risk-aware operating models.

Key segmentation-driven insights revealing how end user profiles, distribution channels, endoscope types, and workflow methods determine solution priorities and procurement choices

Segmentation analysis illuminates how varying clinical environments and procurement pathways shape priorities and investment choices for fluid management systems. Facilities categorized by end user-Ambulatory Surgical Centers, Clinics, Diagnostic Centers, and Hospitals-diverge in scale, case-mix complexity, and capital access. Ambulatory surgical centers and clinics typically prioritize compact, cost-efficient solutions that minimize staff time and footprint, whereas hospitals and large diagnostic centers often seek high-throughput, fully instrumented automation that supports complex procedures and detailed traceability requirements.

Distribution channel considerations further influence procurement strategy and post-sale support expectations. Purchases funneled through direct sales relationships often include stronger service agreements and integrated training, while distributors serve as regional partners that offer broader product assortments and flexible ordering. E-commerce channels, increasingly used for consumables and routine parts, accelerate replenishment cycles but may require enhanced verification processes to ensure compatibility and regulatory compliance.

Endoscope type-flexible versus rigid-also drives equipment and consumable selection. Flexible endoscopes, with intricate lumens and delicate optics, commonly require validated automated or semi-automated reprocessing solutions to meet reproducibility and safety standards, while rigid endoscopes often permit more standardized manual or semi-automated cleaning workflows. Workflow method segmentation distinguishes automated from manual approaches, where automated pathways comprise fully automated and semi-automated systems designed to standardize cycles and capture process data, and manual workflows include manual cleaning and manual high level disinfection practices that depend heavily on technician skill, protocol adherence, and oversight. Understanding how these segmentation dimensions interact enables stakeholders to align technology choices with clinical needs, operational capacity, and regulatory expectations.

Regional dynamics and differentiated adoption patterns across the Americas, Europe Middle East & Africa, and Asia-Pacific shaping procurement, compliance, and commercialization strategies

Regional dynamics shape competitive positioning, regulatory emphasis, and adoption pathways for fluid management solutions across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, a mature clinical market with concentrated infection prevention standards and reimbursement structures often favors validated automation, robust documentation, and strong service networks. Procurement decisions here tend to balance clinical performance with lifecycle costs and operational throughput, reflecting broad adoption of electronic tracking and compliance-focused technologies.

Across Europe, the Middle East & Africa, regulatory heterogeneity and varying infrastructure maturity create a mosaic of needs. Western and northern European providers frequently emphasize environmental considerations and supply chain transparency, prompting interest in both reusable and waste-reducing disposable strategies that meet strict compliance regimes. In contrast, parts of the Middle East and Africa prioritize solutions that deliver reliability under variable logistical constraints, making durability and local serviceability central purchasing criteria.

The Asia-Pacific region presents a mix of high-growth urban markets and resource-constrained settings, driving divergent adoption patterns. Advanced metropolitan centers often adopt cutting-edge automated reprocessing and digitally integrated solutions to support high volumes of endoscopy procedures, while other markets in the region place premium value on cost-efficient workflows, modular systems, and partnership models that support local training and spare parts availability. These regional contrasts underscore the need for suppliers and health systems to tailor commercialization, service, and training models to diverse regulatory and operational contexts.

How vendors are gaining advantage by combining validated automation, modular product design, service excellence, and strategic partnerships to meet clinical and operational demands

Leading companies in the fluid management ecosystem are prioritizing interoperability, validated workflows, and expanded service footprints to capture demand driven by safety and efficiency goals. Strategic initiatives increasingly include integrating reprocessing equipment with instrument tracking platforms, expanding field service networks, and offering training programs that help clinical teams meet evolving regulatory and accreditation standards. Firms that pair robust after-sales support with clear evidence of reprocessing efficacy enhance trust among infection prevention and clinical leaders.

Product strategies are converging around modular architectures that permit phased upgrades and compatibility with a range of endoscope models. This approach reduces switching costs for purchasers and supports more predictable lifecycle planning. At the same time, several vendors are exploring hybrid models that combine reusable device support with complementary single-use offerings, enabling health systems to optimize device mixes according to procedure risk profiles and throughput demands. Where suppliers invest in local manufacturing or regional assembly, they improve supply security and responsiveness, which resonates in markets sensitive to trade disruptions and tariff effects.

Partnerships between device manufacturers, independent service organizations, and software providers are also expanding. These collaborations aim to deliver bundled value propositions that couple validated hardware with digital documentation and process analytics. Companies that successfully demonstrate reductions in reprocessing variability, improvements in traceability, and measurable staff time savings position themselves as strategic partners rather than transactional vendors. Ultimately, competitive advantage accrues to organizations that combine clinical validation, service excellence, and flexible commercial models tailored to diverse care environments.

Practical, high-impact recommendations for clinical, procurement, and supplier leaders to strengthen safety, resilience, and efficiency in fluid management systems

Industry leaders should prioritize a set of targeted actions to align investment with emerging clinical and operational imperatives. First, commit to interoperability and validated documentation capabilities that support compliance and reduce manual recordkeeping burdens. Investing in systems that integrate with existing electronic records and instrument tracking software will streamline workflows and create measurable audit trails that satisfy infection prevention stakeholders. Second, adopt flexible procurement frameworks that allow for hybrid device mixes, enabling facilities to calibrate the balance between reusable and single-use devices based on procedure type, infection risk, and throughput objectives.

Third, strengthen supply chain resilience through regionalized sourcing, dual-supplier arrangements, and inventory strategies that mitigate tariff and logistical disruptions. Suppliers and buyers alike should build contractual mechanisms that share trade-risk and incentivize long-term collaboration on cost and quality improvements. Fourth, expand training and competency programs to reduce variability in manual processes while accelerating the adoption of semi-automated and fully automated workflows; these programs should be evidence-based and linked to measurable quality outcomes. Finally, evaluate sustainability impacts holistically when considering single-use options, accounting for waste management, life-cycle emissions, and regulatory trends. By implementing these recommendations, leaders can better balance clinical safety, operational efficiency, and fiscal responsibility amid a rapidly evolving environment.

A rigorous mixed-method research methodology combining primary interviews, regulatory analysis, vendor mapping, and iterative expert validation to ensure actionable insights

This research synthesized insights from a structured, mixed-method approach designed to ensure analytical rigor and practical relevance. Primary source inputs included in-depth interviews with clinical leaders, infection prevention specialists, procurement executives, and service managers across diverse care settings to capture operational realities and decision drivers. These qualitative inputs were triangulated with a comprehensive review of regulatory guidance, device labeling requirements, and publicly available standards to validate compliance-related observations.

The study also incorporated vendor mapping and supply chain analysis to understand manufacturing footprints, distribution models, and aftermarket support capabilities. Comparative assessments of reprocessing technologies were conducted using documented protocol specifications, validation literature, and case-study evidence from facilities that have implemented automation or hybrid device strategies. Data synthesis emphasized reproducibility: findings were cross-checked with industry experts and refined through iterative validation rounds to ensure clarity and applicability.

Finally, the methodology prioritized transparency and traceability. Assumptions and definitional boundaries were documented, interview protocols were standardized, and data sources were cataloged to support reproducibility. The result is a robust evidence base that connects frontline clinical practice with procurement realities and vendor strategy, offering stakeholders a defensible foundation for decision making.

A concise synthesis highlighting how clinical safety, workflow modernization, and supply chain resilience must align to advance endoscopy fluid management outcomes

In conclusion, endoscopy fluid management will increasingly serve as a focal point where clinical safety, workflow efficiency, and supply chain strategy converge. Technological advances in automation and digital integration, together with shifting preferences around single-use versus reusable devices, create both opportunities and trade-offs for healthcare providers and suppliers. Tariff dynamics and regional variation further complicate procurement and operational planning, underscoring the need for adaptable strategies that prioritize supply resilience and validated performance.

Moving forward, organizations that align clinical protocols, procurement frameworks, and supplier partnerships will capture the greatest benefit. This alignment requires commitment to interoperability, investment in staff competency, and proactive supply chain risk management. By pursuing these priorities, stakeholders can reduce variability in reprocessing, enhance traceability, and make defensible choices that protect patient safety while optimizing resource utilization. The cumulative insight from this analysis equips decision makers with the context and recommendations necessary to navigate a rapidly evolving environment and implement solutions that balance safety, cost, and operational demands.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endoscopy Fluid Management Market, by Endoscope Type

  • 8.1. Flexible Endoscopes
  • 8.2. Rigid Endoscopes

9. Endoscopy Fluid Management Market, by Workflow Method

  • 9.1. Automated
    • 9.1.1. Fully Automated
    • 9.1.2. Semi Automated
  • 9.2. Manual
    • 9.2.1. Manual Cleaning
    • 9.2.2. Manual High Level Disinfection

10. Endoscopy Fluid Management Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Diagnostic Centers
  • 10.4. Hospitals

11. Endoscopy Fluid Management Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributors
  • 11.3. E Commerce

12. Endoscopy Fluid Management Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Endoscopy Fluid Management Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Endoscopy Fluid Management Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Endoscopy Fluid Management Market

16. China Endoscopy Fluid Management Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Arthrex, Inc.
  • 17.6. B. Braun Medical Inc.
  • 17.7. Boston Scientific Corporation
  • 17.8. ConMed Corporation
  • 17.9. Cook Medical LLC
  • 17.10. Fujifilm Holdings Corporation
  • 17.11. Hologic Inc.
  • 17.12. HOYA Corporation
  • 17.13. Johnson & Johnson
  • 17.14. KARL STORZ SE & Co. KG
  • 17.15. Medtronic plc
  • 17.16. Olympus Corporation
  • 17.17. Richard Wolf GmbH
  • 17.18. Smith & Nephew plc
  • 17.19. STERIS plc
  • 17.20. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY ENDOSCOPE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY WORKFLOW METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY WORKFLOW METHOD, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY FULLY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY FULLY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY SEMI AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY SEMI AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY SEMI AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY MANUAL CLEANING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY MANUAL CLEANING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY MANUAL CLEANING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY MANUAL HIGH LEVEL DISINFECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY MANUAL HIGH LEVEL DISINFECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY MANUAL HIGH LEVEL DISINFECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY E COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY E COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY WORKFLOW METHOD, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY WORKFLOW METHOD, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY WORKFLOW METHOD, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY WORKFLOW METHOD, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY WORKFLOW METHOD, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY WORKFLOW METHOD, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY WORKFLOW METHOD, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 101. AFRICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY WORKFLOW METHOD, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY WORKFLOW METHOD, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 115. ASEAN ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 116. ASEAN ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. GCC ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GCC ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. GCC ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY WORKFLOW METHOD, 2018-2032 (USD MILLION)
  • TABLE 121. GCC ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 122. GCC ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 123. GCC ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. GCC ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPEAN UNION ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPEAN UNION ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY WORKFLOW METHOD, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPEAN UNION ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. BRICS ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. BRICS ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY WORKFLOW METHOD, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. G7 ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. G7 ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. G7 ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY WORKFLOW METHOD, 2018-2032 (USD MILLION)
  • TABLE 142. G7 ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 143. G7 ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 144. G7 ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. G7 ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. NATO ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. NATO ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. NATO ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY WORKFLOW METHOD, 2018-2032 (USD MILLION)
  • TABLE 149. NATO ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 150. NATO ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 151. NATO ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. NATO ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. UNITED STATES ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED STATES ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY WORKFLOW METHOD, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. CHINA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY WORKFLOW METHOD, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 166. CHINA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA ENDOSCOPY FLUID MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)